4 news items
InflaRx Hosts R&D Event Highlighting the Promise of INF904
IFRX
5 Jun 24
, and the scope of such protection; our manufacturing capabilities and strategy, including the scalability and cost of our manufacturing methods
InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators
IFRX
21 May 24
property protection for vilobelimab and any other product candidates, and the scope of such protection; our manufacturing capabilities and strategy
InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
IFRX
8 May 24
, and the scope of such protection; our manufacturing capabilities and strategy, including the scalability and cost of our manufacturing methods and processes
InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
IFRX
24 Apr 24
, and the scope of such protection; our manufacturing capabilities and strategy, including the scalability and cost of our manufacturing methods
- Prev
- 1
- Next